hepatocellular carcinoma (HCC), has grown by 25-30% in the past two decades, with much of the growth attributed to the dramatic rise in fatty liver disease, which currently affects 25% of adult ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

The Italian study showed that patients with HCC resulting from viral infections or fatty liver had significantly higher ...

One liver cancer, hepatocellular carcinoma (HCC), is associated ... Both CLD subtypes showed lower gene expression associated with fatty acid metabolism, and Subtype 2 showed higher fatty acid ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

By analysing DNA from blood samples, Tvaster Genkalp is working to make cancer diagnostics more accessible, accurate, and ...

Solute carrier family 25 member 19 (SLC25A19) is a transporter protein of thiamine pyrophosphate across cellular membranes, which is needed as a cofactor for multiple metabolic enzymes and is ...

Hepatocellular carcinoma (HCC) is a common malignant tumor and the third leading cause of cancer-related mortality. The lack ...

Systemic therapy represents the standard of care treatment for patients with advanced hepatocellular carcinoma (HCC). Given the increased risk of death from cirrhosis-related complications in patients ...

The risk of dying from the most common form of primary liver cancer is about 30% higher for patients with low household ...

Both CLD subtypes showed lower gene expression associated with fatty acid ... Analysis of Liver Molecular Dysregulation Leading to Nonviral-Related Hepatocellular Carcinoma Development, Journal ...